From: Clinical implementation of an oncology‐specific family health history risk assessment tool
Characteristics | Completed (n = 102) | GC recommendation (n = 66) | No GC recommendation (n = 36) | p-value | |
---|---|---|---|---|---|
Mean age at enrollmenta (SD) | 55.7 (9.0) | 52.3 (7.8) | 61.9 (7.7) | < 0.001 | |
Mean age at BC diagnosisa (SD) | 52.5 (9.2) | 48.5 (7.5) | 59.9 (7.2) | < 0.001 | |
Mean years from BC diagnosis to enrollmenta (SD) | 3.2 (3.7) | 3.8 (4.2) | 2.0 (2.1) | 0.004 | |
Mean Manchester scorea (SD) | 4.1 (4.3) | 5.7 (4.2) | 1.2 (2.7) | < 0.001 | |
Mean pedigree sizeb,c (SD) | 10.7 (3.6) | 10.7 (3.5) | 10.7 (3.6) | 0.986 | |
Mean % relatives with unknown historyb (SD) | 28.9 (19.5) | 27.3 (17.7) | 31.7 (22.4) | 0.390 | |
Mean % relatives with cancer historyb (SD) | 15.2 (13.6) | 16.9 (14.2) | 12.0 (11.9) | 0.093 | |
Mean % relatives with age of cancer diagnosis reportedb,d (SD) | 93.2 (16.7) | 91.9 (17.5) | 96.0 (14.6) | 0.246 | |
Racea | 0.425 | ||||
Chinese | 67 (65.7) | 45 (68.2) | 22 (61.1) | ||
Malay | 17 (16.7) | 8 (12.1) | 9 (25.0) | ||
Indian | 7 (6.9) | 5 (7.6) | 2 (5.6) | ||
Others | 11 (10.8) | 8 (12.1) | 3 (8.3) | ||
Breast Cancer stagea | 0.760 | ||||
0 | 4 (3.9) | 3 (4.5) | 1 (2.8) | ||
I | 20 (19.6) | 15 (22.7) | 5 (13.9) | ||
II | 46 (45.1) | 28 (42.4) | 18 (50.0) | ||
III | 12 (11.8) | 7 (10.6) | 5 (13.9) | ||
IV | 17 (16.7) | 12 (18.2) | 5 (13.9) | ||
Unknown | 3 (2.9) | 1 (1.5) | 2 (5.6) | ||
GC referral from clinical providera | < 0.001 | ||||
Yes | 24 (23.5) | 24 (36.4) | 0 | ||
No | 78 (76.5) | 42 (63.6) | 36 (100.0) | ||
Clinical providera | 0.902 | ||||
Provider A | 38 (37.3) | 22 (33.3) | 16 (44.4) | ||
Provider B | 36 (35.3) | 25 (37.9) | 11 (30.6) | ||
Provider C | 8 (7.8) | 6 (9.1) | 2 (5.6) | ||
Provider D | 7 (6.9) | 4 (6.1) | 3 (8.3) | ||
Provider E | 7 (6.9) | 5 (7.6) | 2 (5.6) | ||
Provider F | 3 (2.9) | 2 (3.0) | 1 (2.8) | ||
Provider G | 3 (2.9) | 2 (3.0) | 1 (2.8) |